New developments and opportunities in oral mucosal drug delivery for local and systemic disease

Vanessa Hearnden, Vidya Sankar, Katrusha Hull, Danica Vidović Juras, Martin Greenberg, A. Ross Kerr, Peter B. Lockhart, Lauren L. Patton, Stephen Porter, Martin H. Thornhill

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

The oral mucosa's accessibility, excellent blood supply, by-pass of hepatic first-pass metabolism, rapid repair and permeability profile make it an attractive site for local and systemic drug delivery. Technological advances in mucoadhesives, sustained drug release, permeability enhancers and drug delivery vectors are increasing the efficient delivery of drugs to treat oral and systemic diseases. When treating oral diseases, these advances result in enhanced therapeutic efficacy, reduced drug wastage and the prospect of using biological agents such as genes, peptides and antibodies. These technologies are also increasing the repertoire of drugs that can be delivered across the oral mucosa to treat systemic diseases. Trans-mucosal delivery is now a favoured route for non-parenteral administration of emergency drugs and agents where a rapid onset of action is required. Furthermore, advances in drug delivery technology are bringing forward the likelihood of transmucosal systemic delivery of biological agents.

Original languageEnglish (US)
Pages (from-to)16-28
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume64
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Pharmaceutical Preparations
Mouth Diseases
Mouth Mucosa
Biological Factors
Permeability
Technology
Emergencies
Peptides
Antibodies
Liver
Genes
Therapeutics

Keywords

  • Drug delivery technology
  • Formulations
  • Local drug delivery
  • Mucoadhesives
  • Oral mucosa
  • Polymersomes
  • Targeting
  • Trans-mucosal

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Hearnden, V., Sankar, V., Hull, K., Juras, D. V., Greenberg, M., Kerr, A. R., ... Thornhill, M. H. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Advanced Drug Delivery Reviews, 64(1), 16-28. https://doi.org/10.1016/j.addr.2011.02.008

New developments and opportunities in oral mucosal drug delivery for local and systemic disease. / Hearnden, Vanessa; Sankar, Vidya; Hull, Katrusha; Juras, Danica Vidović; Greenberg, Martin; Kerr, A. Ross; Lockhart, Peter B.; Patton, Lauren L.; Porter, Stephen; Thornhill, Martin H.

In: Advanced Drug Delivery Reviews, Vol. 64, No. 1, 01.2012, p. 16-28.

Research output: Contribution to journalArticle

Hearnden, V, Sankar, V, Hull, K, Juras, DV, Greenberg, M, Kerr, AR, Lockhart, PB, Patton, LL, Porter, S & Thornhill, MH 2012, 'New developments and opportunities in oral mucosal drug delivery for local and systemic disease', Advanced Drug Delivery Reviews, vol. 64, no. 1, pp. 16-28. https://doi.org/10.1016/j.addr.2011.02.008
Hearnden, Vanessa ; Sankar, Vidya ; Hull, Katrusha ; Juras, Danica Vidović ; Greenberg, Martin ; Kerr, A. Ross ; Lockhart, Peter B. ; Patton, Lauren L. ; Porter, Stephen ; Thornhill, Martin H. / New developments and opportunities in oral mucosal drug delivery for local and systemic disease. In: Advanced Drug Delivery Reviews. 2012 ; Vol. 64, No. 1. pp. 16-28.
@article{1b39d38328a34badbfe19a5ca5bb9008,
title = "New developments and opportunities in oral mucosal drug delivery for local and systemic disease",
abstract = "The oral mucosa's accessibility, excellent blood supply, by-pass of hepatic first-pass metabolism, rapid repair and permeability profile make it an attractive site for local and systemic drug delivery. Technological advances in mucoadhesives, sustained drug release, permeability enhancers and drug delivery vectors are increasing the efficient delivery of drugs to treat oral and systemic diseases. When treating oral diseases, these advances result in enhanced therapeutic efficacy, reduced drug wastage and the prospect of using biological agents such as genes, peptides and antibodies. These technologies are also increasing the repertoire of drugs that can be delivered across the oral mucosa to treat systemic diseases. Trans-mucosal delivery is now a favoured route for non-parenteral administration of emergency drugs and agents where a rapid onset of action is required. Furthermore, advances in drug delivery technology are bringing forward the likelihood of transmucosal systemic delivery of biological agents.",
keywords = "Drug delivery technology, Formulations, Local drug delivery, Mucoadhesives, Oral mucosa, Polymersomes, Targeting, Trans-mucosal",
author = "Vanessa Hearnden and Vidya Sankar and Katrusha Hull and Juras, {Danica Vidović} and Martin Greenberg and Kerr, {A. Ross} and Lockhart, {Peter B.} and Patton, {Lauren L.} and Stephen Porter and Thornhill, {Martin H.}",
year = "2012",
month = "1",
doi = "10.1016/j.addr.2011.02.008",
language = "English (US)",
volume = "64",
pages = "16--28",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - New developments and opportunities in oral mucosal drug delivery for local and systemic disease

AU - Hearnden, Vanessa

AU - Sankar, Vidya

AU - Hull, Katrusha

AU - Juras, Danica Vidović

AU - Greenberg, Martin

AU - Kerr, A. Ross

AU - Lockhart, Peter B.

AU - Patton, Lauren L.

AU - Porter, Stephen

AU - Thornhill, Martin H.

PY - 2012/1

Y1 - 2012/1

N2 - The oral mucosa's accessibility, excellent blood supply, by-pass of hepatic first-pass metabolism, rapid repair and permeability profile make it an attractive site for local and systemic drug delivery. Technological advances in mucoadhesives, sustained drug release, permeability enhancers and drug delivery vectors are increasing the efficient delivery of drugs to treat oral and systemic diseases. When treating oral diseases, these advances result in enhanced therapeutic efficacy, reduced drug wastage and the prospect of using biological agents such as genes, peptides and antibodies. These technologies are also increasing the repertoire of drugs that can be delivered across the oral mucosa to treat systemic diseases. Trans-mucosal delivery is now a favoured route for non-parenteral administration of emergency drugs and agents where a rapid onset of action is required. Furthermore, advances in drug delivery technology are bringing forward the likelihood of transmucosal systemic delivery of biological agents.

AB - The oral mucosa's accessibility, excellent blood supply, by-pass of hepatic first-pass metabolism, rapid repair and permeability profile make it an attractive site for local and systemic drug delivery. Technological advances in mucoadhesives, sustained drug release, permeability enhancers and drug delivery vectors are increasing the efficient delivery of drugs to treat oral and systemic diseases. When treating oral diseases, these advances result in enhanced therapeutic efficacy, reduced drug wastage and the prospect of using biological agents such as genes, peptides and antibodies. These technologies are also increasing the repertoire of drugs that can be delivered across the oral mucosa to treat systemic diseases. Trans-mucosal delivery is now a favoured route for non-parenteral administration of emergency drugs and agents where a rapid onset of action is required. Furthermore, advances in drug delivery technology are bringing forward the likelihood of transmucosal systemic delivery of biological agents.

KW - Drug delivery technology

KW - Formulations

KW - Local drug delivery

KW - Mucoadhesives

KW - Oral mucosa

KW - Polymersomes

KW - Targeting

KW - Trans-mucosal

UR - http://www.scopus.com/inward/record.url?scp=84858441488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858441488&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2011.02.008

DO - 10.1016/j.addr.2011.02.008

M3 - Article

C2 - 21371513

AN - SCOPUS:84858441488

VL - 64

SP - 16

EP - 28

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 1

ER -